VVOS

Vivos Therapeutics (VVOS)

Vivos Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VVOS

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/26	21:06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/12/24	07:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/12/23	22:00	GlobeNewswire Inc.	Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/12/21	05:17	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/28	07:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/28	06:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/15	06:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/15	06:05	GlobeNewswire Inc.	Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/14	07:00	GlobeNewswire Inc.	Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/11/07	06:15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/10/08	20:30	GlobeNewswire Inc.	Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/25	03:59	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/20	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/20	21:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/19	20:00	GlobeNewswire Inc.	Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/19	06:15	AllPennyStocks.com	Healthcare Shares Pop On FDA Clearance	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/18	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/18	20:00	GlobeNewswire Inc.	Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/18	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/09/13	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/08/15	05:24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/08/15	05:05	GlobeNewswire Inc.	Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/08/14	20:30	GlobeNewswire Inc.	Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/08/09	06:19	Edgar (US Regulatory)	Form 424B1 - Prospectus [Rule 424(b)(1)]	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/08/08	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/07/30	19:17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/07/10	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/06/27	20:30	GlobeNewswire Inc.	Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model	NASDAQ:VVOS	Vivos Therapeutics Inc
2024/06/15	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VVOS	Vivos Therapeutics Inc